PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'CRUK Clinical Trials Unit, University of Glasgow, Glasgow, UK.\', \'NHS Greater Glasgow & Clyde, Glasgow, UK.\', \'Institute of Cancer Sciences, University of Glasgow, Glasgow, UK.\', \'University of Strathclyde, Glasgow, UK.\', \'Department of Pharmacology, University of Liverpool, Liverpool, UK.\', \'Department of Tropical Disease Biology, Liverpool School of Tropical Medicine, Liverpool, UK.\', \'MRC-University of Glasgow Centre for Virus Research, Institute of Infection, Immunity and Inflammation, University of Glasgow, Glasgow, UK.\', \'NHS Greater Glasgow & Clyde, Glasgow, UK. janet.scott@glasgow.ac.uk.\', \'MRC-University of Glasgow Centre for Virus Research, Institute of Infection, Immunity and Inflammation, University of Glasgow, Glasgow, UK. janet.scott@glasgow.ac.uk.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1186/s13063-020-04891-1
?:doi
?:hasPublicationType
?:journal
  • Trials
is ?:pmid of
?:pmid
?:pmid
  • 33213530
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.291
?:rankingScore_hIndex
  • 57
is ?:relation_isRelatedTo_publication of
?:title
  • Glasgow Early Treatment Arm Favirpiravir (GETAFIX) for adults with early stage COVID-19: A structured summary of a study protocol for a randomised controlled trial.
?:type
?:year
  • 2020

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/33213530>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/33213530>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all